Key Segmentation
By Test Type
-
Ancestry and Relationship Testing
-
Health Risk Testing
-
Nutrigenomics and Wellness
-
Carrier Screening
-
Pharmacogenomics
By Technology
-
SNP Chips
-
Whole Genome Sequencing
-
Targeted Analysis
By Sample Type
-
Saliva
-
Blood
-
Others
By Distribution Channel
-
Online Platforms
-
Over-the-Counter
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market player
Frequently Asked Questions
Key players include 23andMe, Ancestry, MyHeritage Ltd., FamilyTreeDNA (Gene By Gene), Helix OpCo, LLC, Color Health, Inc., Living DNA Ltd. and Mapmygenome India Ltd.
Key opportunities include pharmacogenomics, clinical and laboratory partnerships, and expansion into emerging markets in Asia Pacific, Latin America and the Middle East.
The major growth factor is the falling cost of genotyping and sequencing, which allows companies to sell richer reports at consumer prices.
By Test Type, the Ancestry and Relationship Testing segment dominated the market in 2025 with an estimated 36.00% share, supported by low prices and large family databases.
North America dominated the market with a share of 44.00% in 2025, driven by early adoption, online retail and interest in preventive health.
